Lv41
446 积分 2024-05-28 加入
Best practices in the application of parallelism for biomarker assay validation
2天前
已完结
Amivantamab (JNJ-61186372), an Fc Enhanced EGFR/cMet Bispecific Antibody, Induces Receptor Downmodulation and Antitumor Activity by Monocyte/Macrophage Trogocytosis
2个月前
已完结
Discovery of amivantamab (JNJ-61186372), a bispecific antibody targeting EGFR and MET
2个月前
已完结
Use of chicken antibodies in enzyme immunoassays to avoid interference by rheumatoid factors
3个月前
已完结
Overcoming Soluble Target Interference in An Anti-Therapeutic Antibody Screening Assay For An Antibody–Drug Conjugate Therapeutic
3个月前
已关闭
Overcoming target interference in bridging anti-drug antibody (ADA) assay by optimizing sample treatment
4个月前
已完结
Drug Removal Strategies in Competitive Ligand Binding Neutralizing Antibody (NAb) Assays: Highly Drug-Tolerant Methods and Interpreting Immunogenicity Data
4个月前
已完结
Application and interpretation of free and total drug measurements in the development of biologics
5个月前
已完结
Theoretical Analysis of Interplay of Therapeutic Protein Drug and Circulating Soluble Target: Temporal Profiles of ‘Free’ and ‘Total’ Drug and Target
5个月前
已完结
Target Occupancy Biomarker Assay Development Using a Conformation-Selective Antibody Against Small-Molecule-Bound TNF
5个月前
已完结
皖公网安备34019202002308
